Back

Selective induction by statins of FAM134B-mediated sarcoplasmic reticulum (SR)-phagy degrades the SR calcium pump SERCA1 and contributes to myopathy

Ni, L.; Zhao, X.; Zheng, L.; Shimizu, M.; Sasaki, T.; Sakurai, H.; Sato, R.; Yamauchi, Y.

2025-12-01 pharmacology and toxicology
10.1101/2025.11.26.690680 bioRxiv
Show abstract

Statins, HMG-CoA reductase inhibitors, are the most prescribed medication for lowering low-density lipoprotein cholesterol. Although statin intolerance due to statin-associated muscle symptoms (SAMS) has been a clinically important issue for decades, the molecular mechanisms of statin myopathy remain incompletely understood. To seek to clarify how statins induce myopathy, here we perform transcriptome analysis and identify FAM134B short isoform (FAM134B-S), an endoplasmic reticulum (ER)-phagy receptor, as a statin-inducible gene. FAM134B-S expression is regulated by the mevalonate pathway and sterol regulatory element-binding proteins. We further show that FAM134B plays a critical role in the regulation of skeletal muscle integrity both in the steady-state and statin-treated conditions in human iPS cell-derived myocytes and mice. Mechanistically, FAM134B-S interacts with the sarcoplasmic reticulum (SR) calcium pump SERCA1 and promotes its autophagic degradation. Collectively, our work reveals a hitherto undisclosed mechanism of statin myopathy; blocking the mevalonate pathway induces SERCA1 degradation through FAM134B-mediated SR-phagy, exerting myotoxicity.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 17%
11.0%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 11%
9.6%
Similar papers in this journal
3
Journal of Clinical Investigation
● 179 papers in training set
Top 0.4%
7.3%
Similar papers in this journal
4
Science Advances
● 1243 papers in training set
Top 3%
6.2%
Similar papers in this journal
5
Autophagy
○ 39 papers in training set
Top 0.1%
4.8%
Similar papers in this journal
6
Communications Biology
○ 993 papers in training set
Top 5%
3.2%
7
Science Translational Medicine
● 127 papers in training set
Top 0.7%
3.2%
8
Circulation Research
○ 47 papers in training set
Top 0.5%
2.6%
9
JCI Insight
● 277 papers in training set
Top 3%
2.6%
50% of probability mass above
10
Molecular Therapy
○ 81 papers in training set
Top 0.7%
2.4%
11
Advanced Science
○ 286 papers in training set
Top 3%
2.4%
12
Journal of Cachexia, Sarcopenia and Muscle
○ 33 papers in training set
Top 0.2%
2.4%
13
EMBO Reports
○ 263 papers in training set
Top 3%
2.1%
14
Human Molecular Genetics
◐ 141 papers in training set
Top 1%
2.1%
15
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 23%
2.1%
16
iScience
○ 1154 papers in training set
Top 13%
2.1%
17
Cell Death & Disease
147 papers in training set
Top 2%
1.9%
18
Molecular Metabolism
○ 112 papers in training set
Top 1%
1.7%
19
Molecular Cell
○ 350 papers in training set
Top 4%
1.4%
20
Acta Biochimica et Biophysica Sinica
● 23 papers in training set
Top 0.4%
1.1%
21
Stem Cells Translational Medicine
◐ 13 papers in training set
Top 0.2%
1.1%
22
Aging Cell
○ 165 papers in training set
Top 2%
1.1%
23
Cell
○ 431 papers in training set
Top 9%
1.0%
24
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.5%
1.0%
25
Cellular and Molecular Life Sciences
○ 96 papers in training set
Top 2%
0.9%
26
Scientific Reports
○ 3612 papers in training set
Top 72%
0.8%
27
Journal of Biological Chemistry
○ 690 papers in training set
Top 9%
0.8%
28
eBioMedicine
○ 183 papers in training set
Top 6%
0.8%
29
British Journal of Pharmacology
○ 40 papers in training set
Top 0.8%
0.8%
30
Cell Research
○ 51 papers in training set
Top 1%
0.8%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.